Medication info
Metrenin Tablet (Metformin Hydrochloride)

Metrenin Tablet (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201308878 · Approved 2013.08.14 · Insurance code 645604320

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on drug effect and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, treatment with this medicine must be started at a low dose. Take 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week; when administering up to 2000mg, the dose is usually divided into two doses, in the morning and evening. For doses above 2000mg, divide the dose into three daily doses with meals; the maximum daily dose is 2550mg. During treatment initiation and dose adjustment, measure fasting blood glucose to assess response to this medicine and identify the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in a patient whose glucose was previously controlled by diet alone, a short course of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in two divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.
Child dose
Children aged 10 years or older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
  • poor blood sugar control
  • overweight
View approved original text

This medication is used for the treatment of type 2 diabetes in patients whose blood sugar control is insufficient with dietary measures and exercise. It is particularly effective for overweight diabetes patients. In adults, this drug can be used alone or in combination with other oral hypoglycemics or insulin. It can also be used in children over 10 years old and in adolescents during growth as a monotherapy or in combination with insulin. This drug is used to improve blood sugar control and assist in diabetes management.

How to take

Adult dose

The dose should be determined individually based on drug effect and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, treatment with this medicine must be started at a low dose. Take 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week; when administering up to 2000mg, the dose is usually divided into two doses, in the morning and evening. For doses above 2000mg, divide the dose into three daily doses with meals; the maximum daily dose is 2550mg. During treatment initiation and dose adjustment, measure fasting blood glucose to assess response to this medicine and identify the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in a patient whose glucose was previously controlled by diet alone, a short course of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in two divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.

Child dose

Children aged 10 years or older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, and should not be administered, especially to patients with moderate to severe renal impairment or acute illnesses. This medication should not be used in patients with acute and unstable heart failure, acute myocardial infarction, severe infections, dehydration, or those who have had hypersensitivity reactions to this drug or similar drugs. This medication should be discontinued for a certain period before and after tests utilizing iodine contrast agents and can only be resumed after renal function has returned to normal. Pregnant women, or those with placental dysfunction, preeclampsia, or risk of intrauterine growth restriction should avoid using this drug, and if its use is unavoidable, the fetal condition should be closely monitored. This drug is excreted through the kidneys, so regular monitoring of renal function is necessary, and dosage adjustment or discontinuation is required if abnormalities are observed. During treatment, attention should be paid to irregular meals, excessive exercise, and interactions with other medications, especially limiting alcohol consumption. Lactic acidosis is a rare but very serious side effect. Symptoms such as malaise, muscle pain, dyspnea, and abdominal pain should be reported to a physician immediately. Gastrointestinal side effects such as diarrhea, nausea, and vomiting may occur but are usually temporary; dosage adjustment may be necessary if symptoms are severe. This medication can cause vitamin B12 deficiency, so it is important to regularly check vitamin B12 levels during treatment. Elderly patients or those with impaired renal function should be particularly cautious, starting with the minimum dose and regularly monitoring renal function. In case of overdose, the drug can be removed through hemodialysis, so if overdose is suspected, the patient should visit a medical institution immediately. Lastly, while taking this medication, blood sugar control status, renal function, and hematological values should be checked regularly, and any abnormal symptoms should be consulted with medical staff immediately.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • unpleasant taste
Show 8 more
  • metallic taste
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is also advised to avoid extreme temperatures, keeping the medication at a normal room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.